Wendy future of retail top

Craig Vollmer

Soleo Health selected by Genentech to provide two limited distribution drugs

Soleo Health selected by Genentech to provide two limited distribution drugs

McKINNEY, Texas — Soleo Health, an innovative leader in specialty infusion services, announced the company has been selected by Genentech (member of the Roche Group), a world-leading biotechnology company with multiple products on the market and a strong development pipeline, to dispense two limited distribution drugs, Hemlibra and Ocrevus. Hemlibra (emicizumab-kxwh), for patients with hemophilia A with factor VIII inhibitors, received approval from

PP_1170x120_10-25-21